Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Longhorn Vaccines & Diagnostics Announces Poster Presentation at IDWeek 2019

Longhorn Vaccines & Diagnostics an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations, will present scientific data at IDWeek 2019, which will be held in Washington, D.C. on October 2-6.

Updated pre-clinical data will be presented on Longhorn Vaccines & Diagnostics' leading candidates for a universal influenza vaccine. The patented configuration combines multiple conserved regions on the influenza virus. Data will be presented demonstrating strong activity against influenza strains across both group 1 and 2. This approach builds on vaccine candidates that have recently entered the clinical stage that cross strains within groups but not across group. Clara Sei, Director of Microbiology & Immunology Laboratory Longhorn Vaccines & Diagnostics, will present the poster. Further details will be available on the date of presentation.

Presentation Details:

Title: Peptide Vaccines Utilizing Conserved Hemagglutinin, Neuraminidase, and Matrix Ectodomain Influenza Epitopes Demonstrate Functional Activity Against Group 1 and 2 Influenza Strains

Location: Walter E. Washington Convention Center, Exhibit Hall BC

Date: Saturday, October 5

Time: 12:15 pm ET ? 1:30 pm ET

About Longhorn Vaccines and Diagnostics

Longhorn Vaccines & Diagnostics is an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations. Longhorn's core product, PrimeStore® Molecular Transport Medium (MTM), is a patented, FDA approved, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations and drug manufacturers improve the diagnosis and treatment of infectious diseases such as mycobacterium tuberculosis (TB) and Influenza. Unlike standard devices for collecting and transporting TB samples, MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization. Longhorn is based in Bethesda, Maryland.

These press releases may also interest you

at 20:15
Schaumburg Dental Studio offers patients with impacted wisdom teeth in Schaumburg, IL the opportunity to receive wisdom tooth extractions from their experienced general dentists. This not only saves patients time by removing the lengthy referral...

at 19:03
With the goal of providing world-class training and skills advancement tools for research professionals, the Association of Clinical Research Professionals (ACRP) and Pro-ficiency are pleased to announce a strategic partnership. ACRP offers...

at 18:40
As science continues to advance understanding how diseases like cancer and diabetes operate in the human body, the models for treatment have increasingly moved away from one-size-fits-all approaches and toward more individualized therapies. Led by...

at 18:30
The "Tissue and Hygiene Products - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The Tissue and Hygiene Products market worldwide is projected to grow by US$14 Billion, driven by a compounded...

at 18:00
Three of the nation's preeminent spine surgeons, Drs. Todd Lanman, Jason Cuellar and Alexandre Rasouli, of Cedars-Sinai in Los Angeles, served as the principal investigators in a new study published November 7 in the international peer-reviewed Spine...

at 17:58
The food recall warning issued on November 7, 2019 has been updated to include additional distribution information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Taza Food...

News published on 19 september 2019 at 10:05 and distributed by: